Search results for: Professor Adrian Towse
Filter search results
Lung Cancer’s Biggest Test: How Can We Mobilise NGS Testing to Transform Lung Cancer Care?
7 December 2023, 12:00am
…settings. The session ended with a panel discussion and an opportunity for the audience to ask questions to the speakers. THE PANEL Professor Lotte Steuten | Deputy Chief Executive,…
Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe?
1 March 2018
…within them. The lecture was delivered by Professor Case, Sir Angus added some further reflections and then both professors engaged in a question and answer session at the end. The…
OHE’s Mestre-Ferrandiz has new appointment
4 May 2010
…shaping the latest concepts and ideas in health economics. Honorary academic posts current held by other members of the OHE team include the following. Adrian Towse, Visiting Professor at the…
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
…more information on this report please contact Margherita Neri. Neri, M., Towse, A. and Garau, M., 2018. Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward. OHE Briefing. London:…
OHE Launches Discussion Paper and Consultation Exercise on Indication-based Pricing
10 May 2019
…Cole, A., Towse, A. and Zamora, B., 2019. Indication-Based Pricing (IBP) Discussion Paper . OHE Briefing, London: Office of Health Economics. Related research Mestre-Ferrandiz, J., Towse, A., Dellamano, R. and…
Patient Preferences for Diagnostic Tests Aimed at Managing Antimicrobial Resistance
7 October 2019
…European Study of Patient Preferences for Novel Diagnostics to Tackle Antimicrobial Resistance. Applied Health Economics & Health Policy. DOI. Neri, M., Hampson, G., Henshall, C. and Towse, A., 2019. HTA…
A Final MVAC Blueprint—and the Start of an R&D Revolution?
6 February 2020
…available here. (2) Rachel Silverman is a Policy Fellow at the CGD, Kalipso Chalkidou is Director of Global Health Policy and Senior Fellow at the CGD. Citation Chalkidou, K., Garau, M., Silverman, R., and Towse A. (2020)….
Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds
3 March 2020
…Towse (2020) propose a supply and demand model to identify the optimal threshold, based on the framework by Pandey et al. (2018), which has been discussed by the PMPRB Working…
Indication-Based Pricing: Are We All Onboard?
12 May 2020
…The fact that patients were not singled out as the biggest winner by survey respondents remains a major challenge to achieving greater support for IBP. Cole, A., Towse, A. &…